Drug will be recommended based on IHC/Fish, CGH and Pan-XenoBank
SU2C-001
Phase 2 small_molecule completed
Quick answer
Drug will be recommended based on IHC/Fish, CGH and Pan-XenoBank for Previously Treated Metastatic Pancreatic Cancer is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Previously Treated Metastatic Pancreatic Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed